Search Results - "KARADIMITRIS, A"

Refine Results
  1. 1

    Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma by Barbarulo, A, Iansante, V, Chaidos, A, Naresh, K, Rahemtulla, A, Franzoso, G, Karadimitris, A, Haskard, D O, Papa, S, Bubici, C

    Published in Oncogene (05-09-2013)
    “…Regulation of cell survival is a key part of the pathogenesis of multiple myeloma (MM). Jun N-terminal kinase (JNK) signaling has been implicated in MM…”
    Get full text
    Journal Article
  2. 2

    Inadequate fine-tuning of protein synthesis and failure of amino acid homeostasis following inhibition of the ATPase VCP/p97 by Parzych, K, Chinn, T M, Chen, Z, Loaiza, S, Porsch, F, Valbuena, G N, Kleijnen, M F, Karadimitris, A, Gentleman, E, Keun, H C, Auner, H W

    Published in Cell death & disease (01-12-2015)
    “…The cellular mechanisms that control protein degradation may constitute a non-oncogenic cancer cell vulnerability and, therefore, a therapeutic target…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria by KARADIMITRIS, A, LUZZATTO, L

    Published in Leukemia (01-08-2001)
    “…Paroxysmal nocturnal haemoglobinuria (PNH) is a unique disorder characterised by the triad of intravascular haemolysis, thrombosis and bone marrow failure. In…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria by Karadimitris, Anastasios, Manavalan, John S., Thaler, Howard T., Notaro, Rosario, Araten, David J., Nafa, Khedoudja, Roberts, Irene A.G., Weksler, Marc E., Luzzatto, Lucio

    Published in Blood (01-10-2000)
    “…Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of the hematopoietic stem cell (HSC). Somatic mutations in thePIG-Agene result in the…”
    Get full text
    Journal Article
  8. 8

    Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones by ARATEN, D. J, BESSLER, M, MCKENZIE, S, CASTRO-MALASPINA, H, CHILDS, B. H, BOULAD, F, KARADIMITRIS, A, NOTARO, R, LUZZATTO, L

    Published in Leukemia (01-11-2002)
    “…PNH is characterized by expansion of one or more stem cell clones with a PIG-A mutation, which causes a severe deficiency in the expression of…”
    Get full text
    Journal Article
  9. 9

    PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts : implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria by KARADIMITRIS, Anastasios, NOTARO, Rosario, KOEHNE, Gunther, ROBERTS, Irene A. G, LUZZATTO, Lucio

    Published in British journal of haematology (01-12-2000)
    “…The mechanism responsible for the bone marrow failure that is almost invariable in paroxysmal nocturnal haemoglobinuria (PNH) is unknown. Based on the close…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Poly is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma by Barbarulo, A, Iansante, V, Chaidos, A, Naresh, K, Rahemtulla, A, Franzoso, G, Karadimitris, A, Haskard, D.O, Papa, S, Bubici, C

    Published in Oncogene (05-09-2013)
    “…Regulation of cell survival is a key part of the pathogenesis of multiple myeloma (MM). Jun N-terminal kinase (JNK) signaling has been implicated in MM…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Dyskeratosis and ribosomal rebellion by Luzzatto, Lucio, Karadimitris, Anastasios

    Published in Nature genetics (01-05-1998)
    “…Dyskeratosis congenita (DC) is a rare inherited X-linked disorder with a spectrum of clinical manifestations that includes--by definition--remarkable changes…”
    Get full text
    Journal Article
  15. 15

    Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression by Marktel, S, Marin, D, Foot, N, Szydlo, R, Bua, M, Karadimitris, A, De Melo, VA, Kotzampaltiris, P, Dazzi, F, Rahemtulla, A, Olavarria, E, Apperley, JF, Goldman, JM

    Published in Haematologica (Roma) (01-03-2003)
    “…Department of Hematology, Imperial College at Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. BACKGROUND AND OBJECTIVES: The acquisition of additional…”
    Get full text
    Journal Article
  16. 16

    Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria by Karadimitris, Anastasios, Manavalan, John S., Thaler, Howard T., Notaro, Rosario, Araten, David J., Nafa, Khedoudja, Roberts, Irene A.G., Weksler, Marc E., Luzzatto, Lucio

    Published in Blood (01-10-2000)
    “…Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal disorder of the hematopoietic stem cell (HSC). Somatic mutations in thePIG-A gene result in the…”
    Get full text
    Journal Article
  17. 17

    Kinetics, function and bone marrow trafficking of CD4 super(+) CD25 super(+) FOXP3 super(+) regulatory T cells in myelodysplastic syndromes (MDS) by Kotsianidis, I, Bouchliou, I, Nakou, E, Spanoudakis, E, Margaritis, D, Christophoridou, A V, Anastasiades, A, Tsigalou, C, Bourikas, G, Karadimitris, A, Tsatalas, C

    Published in Leukemia (01-03-2009)
    “…CD4 super(+) CD25 super(+) FOXP3 super(+) T regulatory cells (T sub(regs)) prevent autoimmunlty by restricting overexuberant immune responses, but the same…”
    Get full text
    Journal Article
  18. 18

    Kinetics, function and bone marrow trafficking of [CD4.sup.+][CD25.sup.+][FOXP3.sup.+] regulatory T cells in myelodysplastic syndromes (MDS) by Kotsianidis, I, Bouchliou, I, Nakou, E, Spanoudakis, E, Margaritis, D, Christophoridou, A.V, Anastasiades, A, Tsigalou, C, Bourikas, G, Karadimitris, A, Tsatalas, C

    Published in Leukemia (01-03-2009)
    “…[CD4.sup.+][CD25.sup.+][FOXP3.sup.+] T regulatory cells ([T.sub.regs]) prevent autoimmunity by restricting overexuberant immune responses, but the same…”
    Get full text
    Journal Article
  19. 19

    Kinetics, function and bone marrow trafficking of CD4 CD25 FOXP3 regulatory T cells in myelodysplastic syndromes (MDS) by Kotsianidis, I, Bouchliou, I, Nakou, E, Spanoudakis, E, Margaritis, D, Christophoridou, A V, Anastasiades, A, Tsigalou, C, Bourikas, G, Karadimitris, A, Tsatalas, C

    Published in Leukemia (01-03-2009)
    “…CD4 + CD25 + FOXP3 + T regulatory cells (T regs ) prevent autoimmunity by restricting overexuberant immune responses, but the same subpopulation can incur…”
    Get full text
    Journal Article
  20. 20

    Targeted Molecular Therapy for Inherited Glycosylphosphatidylinositol Deficiency by Almeida, A.M., Murakami, Y., Baker, A., Maeda, Y., Roberts, Irene, Kinoshita, Taroh, Layton, D.M., Karadimitris, A.

    Published in Blood (16-11-2006)
    “…Inherited glycosylphosphatidylinositol (GPI) deficiency (IGD) is an autosomal recessive disease characterized by splanchnic vein thrombosis and epilepsy. The…”
    Get full text
    Journal Article